Skip to main content
Stress and Disease Processes Perspectives in Behavioral Medicine

Glycemic responsivity to adrenergic stimulation and genetic predisposition to type II diabetes

Publication ,  Chapter
Surwit, RS
January 1, 2018

Since the 1980s, great strides have been made in the understanding of pathophysiology at the molecular level. Reverse genetic methods have been used to identify the mechanisms by which genetic defects cause a cascade of biochemical events leading to the development of disease. The promise of the molecular genetics has overshadowed much of the importance of conventional physiology and has shifted the focus of many scientists from the whole organism to microparticles. However, it is important to realize that ultimate potential of the molecular approach depends on a thorough understanding of how the organism functions in its environment. The reverse genetic methodology of molecular biology utilizes conventional genetics to map, localize, and clone genes related to disease. This approach is limited by our ability to identify individuals who show the phenotype of a particular disease. Diseases with "variable penetrance" are difficult to study genetically because the phenotype may not always be present in individuals who carry the genotype. One important lesson to come from behavioral medicine research is that many disease phenotypes result from the interaction of environmental stress and genetic predisposition. Acting through neuroendocrine pathways, stress disturbs the function of vulnerable end organ systems in predisposed individuals. This disturbance, if chronic, can lead to a permanent breakdown in function.

Duke Scholars

DOI

Publication Date

January 1, 2018

Start / End Page

235 / 248
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Surwit, R. S. (2018). Glycemic responsivity to adrenergic stimulation and genetic predisposition to type II diabetes. In Stress and Disease Processes Perspectives in Behavioral Medicine (pp. 235–248). https://doi.org/10.4324/9781315827490-13
Surwit, R. S. “Glycemic responsivity to adrenergic stimulation and genetic predisposition to type II diabetes.” In Stress and Disease Processes Perspectives in Behavioral Medicine, 235–48, 2018. https://doi.org/10.4324/9781315827490-13.
Surwit RS. Glycemic responsivity to adrenergic stimulation and genetic predisposition to type II diabetes. In: Stress and Disease Processes Perspectives in Behavioral Medicine. 2018. p. 235–48.
Surwit, R. S. “Glycemic responsivity to adrenergic stimulation and genetic predisposition to type II diabetes.” Stress and Disease Processes Perspectives in Behavioral Medicine, 2018, pp. 235–48. Scopus, doi:10.4324/9781315827490-13.
Surwit RS. Glycemic responsivity to adrenergic stimulation and genetic predisposition to type II diabetes. Stress and Disease Processes Perspectives in Behavioral Medicine. 2018. p. 235–248.

DOI

Publication Date

January 1, 2018

Start / End Page

235 / 248